<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34209958</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>13</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Perturbations of the Proteome and of Secreted Metabolites in Primary Astrocytes from the hSOD1(G93A) ALS Mouse Model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22137028</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease whose pathophysiology is largely unknown. Despite the fact that motor neuron (MN) death is recognized as the key event in ALS, astrocytes dysfunctionalities and neuroinflammation were demonstrated to accompany and probably even drive MN loss. Nevertheless, the mechanisms priming astrocyte failure and hyperactivation are still obscure. In this work, altered pathways and molecules in ALS astrocytes were unveiled by investigating the proteomic profile and the secreted metabolome of primary spinal cord astrocytes derived from transgenic ALS mouse model overexpressing the human (h)SOD1(G93A) protein in comparison with the transgenic counterpart expressing hSOD1(WT) protein. Here we show that ALS primary astrocytes are depleted of proteins-and of secreted metabolites-involved in glutathione metabolism and signaling. The observed increased activation of Nf-kB, Ebf1, and Plag1 transcription factors may account for the augmented expression of proteins involved in the proteolytic routes mediated by proteasome or endosome-lysosome systems. Moreover, hSOD1(G93A) primary astrocytes also display altered lipid metabolism. Our results provide novel insights into the altered molecular pathways that may underlie astrocyte dysfunctionalities and altered astrocyte-MN crosstalk in ALS, representing potential therapeutic targets to abrogate or slow down MN demise in disease pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stella</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1462-4423</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Istituto Zooprofilattico Sperimentale delle Venezie, 35020 Legnaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonadio</LastName><ForeName>Raphael Severino</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0002-4832-2776</Identifier><AffiliationInfo><Affiliation>Department of Biology and CRIBI Biotechnology Center, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cagnin</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7271-4625</Identifier><AffiliationInfo><Affiliation>Department of Biology and CRIBI Biotechnology Center, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIR-Myo Myology Center, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massimino</LastName><ForeName>Maria Lina</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>CNR-Neuroscience Institute, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertoli</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1202-0191</Identifier><AffiliationInfo><Affiliation>CNR-Neuroscience Institute, 35131 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peggion</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9967-2629</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BIRD202151/20</GrantID><Agency>Universit&#xe0; degli Studi di Padova</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber><NameOfSubstance UI="D005978">Glutathione</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">glutathione metabolism</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">proteolysis</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">spinal cord astrocytes</Keyword><Keyword MajorTopicYN="N">transcription factors</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34209958</ArticleId><ArticleId IdType="pmc">PMC8268687</ArticleId><ArticleId IdType="doi">10.3390/ijms22137028</ArticleId><ArticleId IdType="pii">ijms22137028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cleveland D.W., Rothstein J.D. From charcot to lou gehrig: Deciphering selective motor neuron death in als. Nat. Rev. Neurosci. 2001;2:806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg L.H.V.D. Therapy of amyotrophic lateral sclerosis remains a challenge. Lancet Neurol. 2014;13:1062&#x2013;1063. doi: 10.1016/S1474-4422(14)70179-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70179-6</ArticleId><ArticleId IdType="pubmed">25297014</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D., Mansfield C., Moussy A., Hermine O. ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? Front. Aging Neurosci. 2017;9:68. doi: 10.3389/fnagi.2017.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferriere F., Polymenidou M. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Swiss Med. Wkly. 2015;145:w14054. doi: 10.4414/smw.2015.14054.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2015.14054</ArticleId><ArticleId IdType="pubmed">25635517</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Jr., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P.C., Hentati A., Donaldson D.H., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl S.R., Halicek M.T., Mitchell C.S. Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis. J. Neuromuscul. Dis. 2015;2:137&#x2013;150. doi: 10.3233/JND-140068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-140068</ArticleId><ArticleId IdType="pmc">PMC4652798</ArticleId><ArticleId IdType="pubmed">26594635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non&#x2013;cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S.J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS. Exp. Neurobiol. 2016;25:233&#x2013;240. doi: 10.5607/en.2016.25.5.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., Huang H., Peterson A., Hu B., Maragakis N.J., Ming G.-L., Chen H., Zhang S.-C. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Rep. 2017;8:843&#x2013;855. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Maragakis N.J., Rothstein J.D. Mechanisms of Disease: Astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2006;2:679&#x2013;689. doi: 10.1038/ncpneuro0355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0355</ArticleId><ArticleId IdType="pubmed">17117171</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., Turetsky T., Gil Y., Sweetat S., Perez L., Belzer V., Casden N., Steiner D., et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., McManus R., Latz E. Inflammasome signalling in brain function and neurodegenerative disease. Nat. Rev. Neurosci. 2018;19:610&#x2013;621. doi: 10.1038/s41583-018-0055-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0055-7</ArticleId><ArticleId IdType="pubmed">30206330</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena G.N., Tortarolo M., Bendotti C., Cantoni L., Keun H.C. Altered Metabolic Profiles Associate with Toxicity in SOD1G93A Astrocyte-Neuron Co-Cultures. Sci. Rep. 2017;7:50. doi: 10.1038/s41598-017-00072-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00072-4</ArticleId><ArticleId IdType="pmc">PMC5428359</ArticleId><ArticleId IdType="pubmed">28246392</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyrat-Durebex C., Corcia P., Piver E., Devos D., Dangoumau A., Gouel F., Vourc H.P., Emond P., Laumonnier F., Nadal-Desbarats L., et al. Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2015;53:6910&#x2013;6924. doi: 10.1007/s12035-015-9567-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9567-6</ArticleId><ArticleId IdType="pubmed">26666663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hounoum B.M., Mavel S., Coque E., Patin F., Vourc H.P., Marouillat S., Nadal-Desbarats L., Emond P., Corcia P., Andres C., et al. Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia. 2017;65:592&#x2013;605. doi: 10.1002/glia.23114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23114</ArticleId><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P., Cassina A., Pehar M., Castellanos R., Gandelman M., De Le&#xf3;n A., Robinson K.M., Mason R.P., Beckman J.S., Barbeito L., et al. Mitochondrial Dysfunction in SOD1G93A-Bearing Astrocytes Promotes Motor Neuron Degeneration: Prevention by Mitochondrial-Targeted Antioxidants. J. Neurosci. 2008;28:4115&#x2013;4122. doi: 10.1523/JNEUROSCI.5308-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5308-07.2008</ArticleId><ArticleId IdType="pmc">PMC3844766</ArticleId><ArticleId IdType="pubmed">18417691</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F., Brambilla L., Valori C.F., Bergamaschi C., Roncoroni C., Aronica E., Volterra A., Bezzi P., Rossi D. The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum. Mol. Genet. 2012;21:826&#x2013;840. doi: 10.1093/hmg/ddr513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr513</ArticleId><ArticleId IdType="pubmed">22072391</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H., Ng S.K., Diaz N., Burstein S., Morel L., Osgood A., Sider B., Higashimori H., Haydon P.G., Manfredi G., et al. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J. Neurosci. 2014;34:2331&#x2013;2348. doi: 10.1523/JNEUROSCI.2689-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2689-13.2014</ArticleId><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Norante R.P., Peggion C., Rossi D., Martorana F., De Mario A., Lia A., Massimino M.L., Bertoli A., Mario D., Lia A.L.S. Associated SOD1(G93A) Decreases SERCA Pump Levels and Increases Store-Operated Ca2 + Entry in Primary Spinal Cord Astrocytes from a Transgenic Mouse Model. Int. J. Mol. Sci. 2019;20:5151. doi: 10.3390/ijms20205151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205151</ArticleId><ArticleId IdType="pmc">PMC6829245</ArticleId><ArticleId IdType="pubmed">31627428</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Carrasco M., Siao M.C., Maniatis T., Eggan K. Non&#x2013;cell autonomous effect of glia on motor neurons in an embryonic stem cell&#x2013;based ALS model. Nat. Neurosci. 2007;10:608&#x2013;614. doi: 10.1038/nn1885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Rodriguez-Muela N., Klim J.R., de Boer A.S., Agrawal S., Sandoe J., Lopes C.S., Ogliari K.S., Williams L.A., Shear M., et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-beta. Stem Cell Rep. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizcaino J.A., C&#xf4;t&#xe9; R.G., Reisinger F., Barsnes H., Foster J.M., Rameseder J., Hermjakob H., Martens L. The Proteomics Identifications database: 2010 update. Nucleic Acids Res. 2009;38:D736&#x2013;D742. doi: 10.1093/nar/gkp964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp964</ArticleId><ArticleId IdType="pmc">PMC2808904</ArticleId><ArticleId IdType="pubmed">19906717</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Cha S.J., Choi H.-J., Kim K. Omega Class Glutathione S-Transferase: Antioxidant Enzyme in Pathogenesis of Neurodegenerative Diseases. Oxidative Med. Cell. Longev. 2017;2017:1&#x2013;6. doi: 10.1155/2017/5049532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/5049532</ArticleId><ArticleId IdType="pmc">PMC5757135</ArticleId><ArticleId IdType="pubmed">29435097</ArticleId></ArticleIdList></Reference><Reference><Citation>Van De Giessen E., Fogh I., Gopinath S., Smith B., Hu X., Powell J., Andersen P., Nicholson G., Al Chalabi A., Shaw C.E. Association study on glutathione S?transferase omega 1 and 2 and familial ALS. Amyotroph. Lateral Scler. 2008;9:81&#x2013;84. doi: 10.1080/17482960701702553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701702553</ArticleId><ArticleId IdType="pubmed">18427999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi L., Ke Y., Luo C., Gozal D., Liu R. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience. 2007;144:991&#x2013;1003. doi: 10.1016/j.neuroscience.2006.09.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.09.064</ArticleId><ArticleId IdType="pmc">PMC1944995</ArticleId><ArticleId IdType="pubmed">17150307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Bai Z., Qin X., Cheng Y. Aberrations in Oxidative Stress Markers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Oxidative Med. Cell. Longev. 2019;2019:1&#x2013;9. doi: 10.1155/2019/1712323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1712323</ArticleId><ArticleId IdType="pmc">PMC6590548</ArticleId><ArticleId IdType="pubmed">31281567</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessandro G., Calcagno E., Tartari S., Rizzardini M., Invernizzi R.W., Cantoni L. Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism. Neurobiol. Dis. 2011;43:346&#x2013;355. doi: 10.1016/j.nbd.2011.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.04.003</ArticleId><ArticleId IdType="pubmed">21530659</ArticleId></ArticleIdList></Reference><Reference><Citation>Silacci P., Mazzolai L., Gauci C., Stergiopulos N., Yin H.L., Hayoz D. Gelsolin superfamily proteins: Key regulators of cellular functions. Cell. Mol. Life Sci. 2004;61:2614&#x2013;2623. doi: 10.1007/s00018-004-4225-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4225-6</ArticleId><ArticleId IdType="pubmed">15526166</ArticleId></ArticleIdList></Reference><Reference><Citation>Merienne N., Meunier C., Schneider A., Seguin J., Nair S.S., Rocher A.B., Le Gras S., Keime C., Faull R., Pellerin L., et al. Cell-Type-Specific Gene Expression Profiling in Adult Mouse Brain Reveals Normal and Disease-State Signatures. Cell Rep. 2019;26:2477&#x2013;2493. doi: 10.1016/j.celrep.2019.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.003</ArticleId><ArticleId IdType="pubmed">30811995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakai H., Fujii Y., Kuwayama N., Kawaji K., Gotoh Y., Kishi Y. Plag1 regulates neuronal gene expression and neuronal differentiation of neocortical neural progenitor cells. Genes Cells. 2019;24:650&#x2013;666. doi: 10.1111/gtc.12718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12718</ArticleId><ArticleId IdType="pubmed">31442350</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y.H., Joo K.M., Lee Y.J., Kim M.J., Cha C.I. Reactive astrocytes express cAMP-response-element-binding protein (CREB) binding protein (CBP) in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation. Neurosci. Lett. 2003;343:159&#x2013;162. doi: 10.1016/S0304-3940(03)00353-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(03)00353-7</ArticleId><ArticleId IdType="pubmed">12770687</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckinghaus A., Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 2009;1:a000034. doi: 10.1101/cshperspect.a000034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000034</ArticleId><ArticleId IdType="pmc">PMC2773619</ArticleId><ArticleId IdType="pubmed">20066092</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L. The non-cell-autonomous component of ALS: New in vitro models and future challenges. Biochem. Soc. Trans. 2014;42:1270&#x2013;1274. doi: 10.1042/BST20140168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20140168</ArticleId><ArticleId IdType="pubmed">25233402</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostalski H., Leskel&#xe4; S., Huber N., Katisko K., Cajanus A., Solje E., Marttinen M., Natunen T., Remes A.M., Hiltunen M., et al. Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS. Front. Neurosci. 2019;13:486. doi: 10.3389/fnins.2019.00486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00486</ArticleId><ArticleId IdType="pmc">PMC6529740</ArticleId><ArticleId IdType="pubmed">31156371</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil R.S., Clarke B., Ecroyd H., Kalmar B., Greensmith L. Regional Differences in Heat Shock Protein 25 Expression in Brain and Spinal Cord Astrocytes of Wild-Type and SOD1 G93A Mice. Cells. 2021;10:1257. doi: 10.3390/cells10051257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10051257</ArticleId><ArticleId IdType="pmc">PMC8160835</ArticleId><ArticleId IdType="pubmed">34069691</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker D.J., Blackburn D.J., Keatinge M., Sokhi D., Viskaitis P., Heath P.R., Ferraiuolo L., Kirby J., Shaw P. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93 A mouse model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2015;9:410. doi: 10.3389/fncel.2015.00410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00410</ArticleId><ArticleId IdType="pmc">PMC4606544</ArticleId><ArticleId IdType="pubmed">26528138</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M.C., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., Gage F.H. Non-Cell-Autonomous Effect of Human SOD1G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells. Cell Stem Cell. 2008;3:649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M., Vallarola A., Lidonnici D., Battaglia E., Gensano F., Spaltro G., Fiordaliso F., Corbelli A., Garetto S., Martini E., et al. Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression. J. Neurochem. 2015;135:109&#x2013;124. doi: 10.1111/jnc.13154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13154</ArticleId><ArticleId IdType="pubmed">25940956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendon&#xe7;a D., Chimelli L., Martinez A. Expression of ubiquitin and proteasome in motorneurons and astrocytes of spinal cords from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2006;404:315&#x2013;319. doi: 10.1016/j.neulet.2006.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.06.009</ArticleId><ArticleId IdType="pubmed">16806703</ArticleId></ArticleIdList></Reference><Reference><Citation>Seilhean D., Takahashi J., El Hachimi K.H., Fujigasaki H., Lebre A.-S., Biancalana V., Durr A., Salachas F., Hogenhuis J., De Th&#xe9; H., et al. Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions. Acta Neuropathol. 2004;108:81&#x2013;87. doi: 10.1007/s00401-004-0855-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0855-x</ArticleId><ArticleId IdType="pubmed">15114487</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., Rothstein J.D. Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues. Neurobiol. Dis. 2001;8:933&#x2013;941. doi: 10.1006/nbdi.2001.0443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0443</ArticleId><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#x161;lar A., Kos J. Cysteine Cathepsins in Neurological Disorders. Mol. Neurobiol. 2014;49:1017&#x2013;1030. doi: 10.1007/s12035-013-8576-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8576-6</ArticleId><ArticleId IdType="pubmed">24234234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M., Valenzuela V., Rojas-Rivera D., Vidal R., Matus S., Castillo K., Fuentealba Y., Kroemer G., Levine B., Hetz C. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy. 2014;10:1256&#x2013;1271. doi: 10.4161/auto.28784.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.28784</ArticleId><ArticleId IdType="pmc">PMC4203551</ArticleId><ArticleId IdType="pubmed">24905722</ArticleId></ArticleIdList></Reference><Reference><Citation>Conus S., Simon H.-U. Cathepsins: Key modulators of cell death and inflammatory responses. Biochem. Pharmacol. 2008;76:1374&#x2013;1382. doi: 10.1016/j.bcp.2008.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2008.07.041</ArticleId><ArticleId IdType="pubmed">18762176</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukada Y., Yasui K., Kitayama M., Doi K., Nakano T., Watanabe Y., Nakashima K. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: Studies of the Leu126delTT mutation in SOD. Brain Res. 2007;1160:1&#x2013;10. doi: 10.1016/j.brainres.2007.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.05.044</ArticleId><ArticleId IdType="pubmed">17583678</ArticleId></ArticleIdList></Reference><Reference><Citation>De Aguilar J.-L.G., Niederhauser-Wiederkehr C., Halter B., de Tapia M., Di Scala F., Demougin P., Dupuis L., Primig M., Meininger V., Loeffler J.-P., et al. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol. Genom. 2008;32:207&#x2013;218. doi: 10.1152/physiolgenomics.00017.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00017.2007</ArticleId><ArticleId IdType="pubmed">18000159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendt W., Lufcbbert H., Stichel C.C. Upregulation of cathepsin S in the aging and pathological nervous system of mice. Brain Res. 2008;1232:7&#x2013;20. doi: 10.1016/j.brainres.2008.07.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.07.067</ArticleId><ArticleId IdType="pubmed">18694734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wootz H., Weber E., Korhonen L., Lindholm D. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: Possible roles in motor neuron survival. Neuroscience. 2006;143:419&#x2013;430. doi: 10.1016/j.neuroscience.2006.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.07.048</ArticleId><ArticleId IdType="pubmed">16973300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H., Yamada T., Furuya H., Doh-Ura K., Ohyagi Y., Iwaki T., Kira J.-I. Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis. Acta Neuropathol. 2003;105:462&#x2013;468. doi: 10.1007/s00401-002-0667-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-002-0667-9</ArticleId><ArticleId IdType="pubmed">12677446</ArticleId></ArticleIdList></Reference><Reference><Citation>Tropak M.B., Mahuran D. Lending a helping hand, screening chemical libraries for compounds that enhance &#x3b2;-hexosaminidase A activity in GM2 gangliosidosis cells. FEBS J. 2007;274:4951&#x2013;4961. doi: 10.1111/j.1742-4658.2007.06040.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2007.06040.x</ArticleId><ArticleId IdType="pmc">PMC2910757</ArticleId><ArticleId IdType="pubmed">17894780</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi H., Okamoto T., Hara Y., Komine O., Tamada H., Maeda M., Osako F., Kobayashi M., Nishiyama A., Kataoka Y., et al. Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunction. EMBO J. 2020;39:e104464. doi: 10.15252/embj.2020104464.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020104464</ArticleId><ArticleId IdType="pmc">PMC7667883</ArticleId><ArticleId IdType="pubmed">32959911</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez A., Mas A., Heras V.D.L., Arroyo R., Fern&#xe1;ndez-Arquero M., De La Concha E.G., Urcelay E. Early B-cell Factor gene association with multiple sclerosis in the Spanish population. BMC Neurol. 2005;5:19. doi: 10.1186/1471-2377-5-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-5-19</ArticleId><ArticleId IdType="pmc">PMC1291372</ArticleId><ArticleId IdType="pubmed">16255771</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Phaneuf D., Dupr&#xe9; N., Petri S., Strong M., Kriz J., Julien J.-P. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor &#x3ba;B-mediated pathogenic pathways. J. Exp. Med. 2011;208:2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M., Miranda C., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosio C., Valle C., Casciati A., Iaccarino C., Carr&#xec; M.T. Astroglial Inhibition of NF-&#x3ba;B Does Not Ameliorate Disease Onset and Progression in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS) PLoS ONE. 2011;6:e17187. doi: 10.1371/journal.pone.0017187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017187</ArticleId><ArticleId IdType="pmc">PMC3060799</ArticleId><ArticleId IdType="pubmed">21445241</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollari E., Goldsteins G., Bart G., Koistinaho J., Giniatullin R. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:131. doi: 10.3389/fncel.2014.00131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00131</ArticleId><ArticleId IdType="pmc">PMC4026683</ArticleId><ArticleId IdType="pubmed">24860432</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Garcon G., Patin F., Veyrat-Durebex C., Boyer J., Devos D., Vourc&#x2019;H P., Andres C., Corcia P. Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study. Can. J. Neurol. Sci. 2017;44:90&#x2013;95. doi: 10.1017/cjn.2016.284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.284</ArticleId><ArticleId IdType="pubmed">27774920</ArticleId></ArticleIdList></Reference><Reference><Citation>Dringen R., Brandmann M., Hohnholt M.C., Blumrich E.-M. Glutathione-Dependent Detoxification Processes in Astrocytes. Neurochem. Res. 2015;40:2570&#x2013;2582. doi: 10.1007/s11064-014-1481-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-014-1481-1</ArticleId><ArticleId IdType="pubmed">25428182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Qin C., Huang J., Tang X., Liu C., Huang K., Xu J., Guo G., Tong A., Zhou L. The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. Cell Prolif. 2020;53:e12781. doi: 10.1111/cpr.12781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12781</ArticleId><ArticleId IdType="pmc">PMC7106951</ArticleId><ArticleId IdType="pubmed">32035016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S.C. Glutathione synthesis. Biochim. Biophys. Acta&#x2014;Gen. Subj. 2013;1830:3143&#x2013;3153. doi: 10.1016/j.bbagen.2012.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2012.09.008</ArticleId><ArticleId IdType="pmc">PMC3549305</ArticleId><ArticleId IdType="pubmed">22995213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarlette A., Krampfl K., Grothe C., Von Neuhoff N., Dengler R., Petri S. Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2008;67:1055&#x2013;1062. doi: 10.1097/NEN.0b013e31818b4906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31818b4906</ArticleId><ArticleId IdType="pubmed">18957896</ArticleId></ArticleIdList></Reference><Reference><Citation>Neymotin A., Calingasan N.Y., Wille E., Naseri N., Petri S., Damiano M., Liby K.T., Risingsong R., Sporn M., Beal M.F., et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2011;51:88&#x2013;96. doi: 10.1016/j.freeradbiomed.2011.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.03.027</ArticleId><ArticleId IdType="pmc">PMC3109235</ArticleId><ArticleId IdType="pubmed">21457778</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S., K&#xf6;rner S., Kiaei M. Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS. Neurol. Res. Int. 2012;2012:1&#x2013;7. doi: 10.1155/2012/878030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/878030</ArticleId><ArticleId IdType="pmc">PMC3461296</ArticleId><ArticleId IdType="pubmed">23050144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachhawat A.K., Yadav S. The glutathione cycle: Glutathione metabolism beyond the &#x3b3;-glutamyl cycle. IUBMB Life. 2018;70:585&#x2013;592. doi: 10.1002/iub.1756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1756</ArticleId><ArticleId IdType="pubmed">29667297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofyanovich O.A., Nishiuchi H., Yamagishi K., Matrosova E.V., Serebrianyi V.A. Multiple pathways for the formation of the &#x3b3;-glutamyl peptides &#x3b3;-glutamyl-valine and &#x3b3;- glutamyl-valyl-glycine in Saccharomyces cerevisiae. PLoS ONE. 2019;14:e0216622. doi: 10.1371/journal.pone.0216622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0216622</ArticleId><ArticleId IdType="pmc">PMC6508711</ArticleId><ArticleId IdType="pubmed">31071163</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu G.N., Kumar A., Chandra R., Puri S., Singh R., Kalita J., Misra U. Oxidant&#x2013;antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem. Int. 2008;52:1284&#x2013;1289. doi: 10.1016/j.neuint.2008.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2008.01.009</ArticleId><ArticleId IdType="pubmed">18308427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma M., Jamrozik Z., Bara&#x144;czyk-Ku&#x17a;ma A. Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis. Clin. Chim. Acta. 2006;364:217&#x2013;221. doi: 10.1016/j.cccn.2005.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cccn.2005.07.008</ArticleId><ArticleId IdType="pubmed">16109392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha S.J., Han Y.J., Choi H.-J., Kim H.-J., Kim K. Glutathione S-Transferase Rescues Motor Neuronal Toxicity in Fly Model of Amyotrophic Lateral Sclerosis. Antioxidants. 2020;9:615. doi: 10.3390/antiox9070615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9070615</ArticleId><ArticleId IdType="pmc">PMC7402175</ArticleId><ArticleId IdType="pubmed">32674363</ArticleId></ArticleIdList></Reference><Reference><Citation>Filho A.D.B.C., Pinto I.F.D., Dantas L.S., Xavier A.M., Inague A., Faria R.L., Medeiros M.H.G., Glezer I., Yoshinaga M.Y., Miyamoto S. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci. Rep. 2019;9:1&#x2013;14. doi: 10.1038/s41598-019-48059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey T., Kirk S., Steyn F., Ngo S. The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Semin. Cell Dev. Biol. 2020;112:69&#x2013;81. doi: 10.1016/j.semcdb.2020.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.08.012</ArticleId><ArticleId IdType="pubmed">32962914</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey T.J., Steyn F.J., Wolvetang E.J., Ngo S.T. Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease. Front. Mol. Neurosci. 2018;11:10. doi: 10.3389/fnmol.2018.00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00010</ArticleId><ArticleId IdType="pmc">PMC5787076</ArticleId><ArticleId IdType="pubmed">29410613</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang S.-N., Lee J., Seo K., Lee H. Astrocytic Regulation of Neural Circuits Underlying Behaviors. Cells. 2021;10:296. doi: 10.3390/cells10020296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020296</ArticleId><ArticleId IdType="pmc">PMC7912785</ArticleId><ArticleId IdType="pubmed">33535587</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y.-B., Gao W., Zhang Y., Jia F., Zhang H.-L., Liu Y.-Z., Sun X.-F., Yin Y., Yin D.-M. Astrocyte-derived phosphatidic acid promotes dendritic branching. Sci. Rep. 2016;6:21096. doi: 10.1038/srep21096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21096</ArticleId><ArticleId IdType="pmc">PMC4756377</ArticleId><ArticleId IdType="pubmed">26883475</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Mavel S., Corcia P., Gordon P. The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development. Curr. Med. Chem. 2014;21:3551&#x2013;3575. doi: 10.2174/0929867321666140916120118.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867321666140916120118</ArticleId><ArticleId IdType="pubmed">25245510</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto M.C., Gurney M.E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS) Brain Res. 1995;676:25&#x2013;40. doi: 10.1016/0006-8993(95)00063-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(95)00063-V</ArticleId><ArticleId IdType="pubmed">7796176</ArticleId></ArticleIdList></Reference><Reference><Citation>Norante R.P., Massimino M.L., Lorenzon P., De Mario A., Peggion C., Vicario M., Albiero M., Sorgato M.C., Lopreiato R., Bertoli A. Generation and validation of novel adeno-associated viral vectors for the analysis of Ca2 + homeostasis in motor neurons. Sci. Rep. 2017;7:6521. doi: 10.1038/s41598-017-06919-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06919-0</ArticleId><ArticleId IdType="pmc">PMC5529510</ArticleId><ArticleId IdType="pubmed">28747684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez E., Mu&#xf1;oz M., Sim&#xf3; C., Ib&#xe1;&#xf1;ez C., Carrocera S., Mart&#xed;n-Gonz&#xe1;lez D., Cifuentes A. Non-invasive metabolomics for improved determination of embryonic sex markers in chemically defined culture medium. J. Chromatogr. A. 2016;1474:138&#x2013;144. doi: 10.1016/j.chroma.2016.10.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2016.10.080</ArticleId><ArticleId IdType="pubmed">27823786</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella R., Bovo D., Mastrorilli E., Manuali E., Pezzolato M., Bozzetta E., Lega F., Angeletti R., Biancotto G. A novel tool to screen for treatments with clenbuterol in bovine: Identification of two hepatic markers by metabolomics investigation. Food Chem. 2021;353:129366. doi: 10.1016/j.foodchem.2021.129366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2021.129366</ArticleId><ArticleId IdType="pubmed">33838430</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi&#x15b;niewski J.R., Zougman A., Nagaraj N., Mann M. Universal sample preparation method for proteome analysis. Nat. Methods. 2009;6:359&#x2013;362. doi: 10.1038/nmeth.1322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1322</ArticleId><ArticleId IdType="pubmed">19377485</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancotto G., Bovo D., Mastrorilli E., Manuali E., Angeletti R., Stella R. TMT-Based Proteomics Profiling of Bovine Liver Underscores Protein Markers of Anabolic Treatments. Proteomics. 2019;19:e1800422. doi: 10.1002/pmic.201800422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201800422</ArticleId><ArticleId IdType="pubmed">30865377</ArticleId></ArticleIdList></Reference><Reference><Citation>Peggion C., Massimino M.L., Stella R., Bortolotto R., Agostini J., Maldi A., Sartori G., Tonello F., Bertoli A., Lopreiato R. Nucleolin Rescues TDP-43 Toxicity in Yeast and Human Cell Models. Front. Cell. Neurosci. 2021;15:115. doi: 10.3389/fncel.2021.625665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.625665</ArticleId><ArticleId IdType="pmc">PMC8072491</ArticleId><ArticleId IdType="pubmed">33912014</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen E.Y., Tan C.M., Kou Y., Duan Q., Wang Z., Meirelles G.V., Clark N.R., Ma&#x2019;Ayan A. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128. doi: 10.1186/1471-2105-14-128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Bailey A., Kuleshov M.V., Clarke D.J.B., Evangelista J.E., Jenkins S.L., Lachmann A., Wojciechowicz M.L., Kropiwnicki E., Jagodnik K.M., et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 2021;1:e90. doi: 10.1002/cpz1.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.90</ArticleId><ArticleId IdType="pmc">PMC8152575</ArticleId><ArticleId IdType="pubmed">33780170</ArticleId></ArticleIdList></Reference><Reference><Citation>Moritz C.P. Tubulin or Not Tubulin: Heading Toward Total Protein Staining as Loading Control in Western Blots. Proteomics. 2017;17:1600189. doi: 10.1002/pmic.201600189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201600189</ArticleId><ArticleId IdType="pubmed">28941183</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon A.T., Arenillas D.J., Worsley Hunt R., Wasserman W.W. oPOSSUM-3: Advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets. G3. 2012;2:987&#x2013;1002. doi: 10.1534/g3.112.003202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.112.003202</ArticleId><ArticleId IdType="pmc">PMC3429929</ArticleId><ArticleId IdType="pubmed">22973536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambelli F., Pesole G., Pavesi G. Pscan: Finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res. 2009;37:W247&#x2013;W252. doi: 10.1093/nar/gkp464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp464</ArticleId><ArticleId IdType="pmc">PMC2703934</ArticleId><ArticleId IdType="pubmed">19487240</ArticleId></ArticleIdList></Reference><Reference><Citation>Defrance M., Touzet H. Predicting transcription factor binding sites using local over-representation and comparative genomics. BMC Bioinform. 2006;7:396. doi: 10.1186/1471-2105-7-396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-7-396</ArticleId><ArticleId IdType="pmc">PMC1570149</ArticleId><ArticleId IdType="pubmed">16945132</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandelin A., Alkema W., Engstr&#xf6;m P., Wasserman W., Lenhard B. JASPAR: An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004;32:91D&#x2013;94. doi: 10.1093/nar/gkh012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh012</ArticleId><ArticleId IdType="pmc">PMC308747</ArticleId><ArticleId IdType="pubmed">14681366</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveros J.C. Venny. An interactive tool for comparing lists with Venn Diagrams.  [(accessed on 28 June 2021)];2007  Available online:  https://bioinfogp.cnb.csic.es/tools/venny/index.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>